Filing Details
- Accession Number:
- 0001209191-23-049826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-18 19:03:40
- Reporting Period:
- 2023-09-14
- Accepted Time:
- 2023-09-18 19:03:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1782223 | Pyxis Oncology Inc. | PYXS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769457 | Lara Sullivan | C/O Pyxis Oncology, Inc. 321 Harrison Avenue Boston MA 02118 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-09-14 | 100 | $2.25 | 2,412,423 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-18 | 8,541 | $2.10 | 2,403,882 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
